[논문]whISOBAX TM Inhibits Bacterial Pathogenesis and Enhances the Effect of Antibiotics

Rasooly, Reuven; Choi, Hwang-Yong; Do, Paula; Morroni, Gianluca; Brescini, Lucia; Cirioni, Oscar; Giacometti, Andrea; Apostolidis, Emmanouil

doi:10.3390/antibiotics9050264

whISOBAX TM Inhibits Bacterial Pathogenesis and Enhances the Effect of Antibiotics 원문보기

Antibiotics, v.9 no.5, 2020년, pp.264 -

Rasooly, Reuven (U.S. Department of Agriculture, Agricultural Research Service, Albany, CA 94710, USA) , Choi, Hwang-Yong (paula.do@usda.gov) , Do, Paula (Department of Chemistry and Food Science, Framingham State University, Framingham, MA 01701, USA) , Morroni, Gianluca (kelolo123123@gmail.com) , Brescini, Lucia (U.S. Department of Agriculture, Agricultural Research Service, Albany, CA 94710, USA) , Cirioni, Oscar (paula.do@usda.gov) , Giacometti, Andrea (Department of Biomedical Sciences and Public Health, Marche Polytechnic University, 60121 Ancona, Italy) , Apostolidis, Emmanouil (lucia.brescini@ospedaliriuniti.marche.it (L.B.))

Abstract ▼ AI-Helper

As bacteria are becoming more resistant to commonly used antibiotics, alternative therapies are being sought. whISOBAX (WH) is a witch hazel extract that is highly stable (tested up to 2 months in 37 °C) and contains a high phenolic content, where 75% of it is hamamelitannin and traces of gallic acid. Phenolic compounds like gallic acid are known to inhibit bacterial growth, while hamamelitannin is known to inhibit staphylococcal pathogenesis (biofilm formation and toxin production). WH was tested in vitro for its antibacterial activity against clinically relevant Gram-positive and Gram-negative bacteria, and its synergy with antibiotics determined using checkerboard assays followed by isobologram analysis. WH was also tested for its ability to suppress staphylococcal pathogenesis, which is the cause of a myriad of resistant infections. Here we show that WH inhibits the growth of all bacteria tested, with variable efficacy levels. The most WH-sensitive bacteria tested were Staphylococcus epidermidis,Staphylococcus aureus, Enterococcus faecium and Enterococcus faecalis, followed by Acinetobacter baumannii, Klebsiella pneumoniae, Escherichia coli,Pseudomonas aeruginosa, Streptococcus agalactiae and Streptococcus pneumoniae. Furthermore, WH was shown on S. aureus to be synergistic to linezolid and chloramphenicol and cumulative to vancomycin and amikacin. The effect of WH was tested on staphylococcal pathogenesis and shown here to inhibit biofilm formation (tested on S. epidermidis) and toxin production (tested on S. aureus Enterotoxin A (SEA)). Toxin inhibition was also evident in the presence of subinhibitory concentrations of ciprofloxacin that induces pathogenesis. Put together, our study indicates that WH is very effective in inhibiting the growth of multiple types of bacteria, is synergistic to antibiotics, and is also effective against staphylococcal pathogenesis, often the cause of persistent infections. Our study thus suggests the benefits of using WH to combat various types of bacterial infections, especially those that involve resistant persistent bacterial pathogens.

주제어

참고문헌 (48)

1. Vestergaard M. Frees D. Ingmer H. Antibiotic Resistance and the MRSA Problem Microbiol. Spectr. 2019 7 10.1128/microbiolspec.GPP3-0057-2018

상세보기
2. Danna D.M. Hospital Costs Associated with Sepsis Compared with Other Medical Conditions Crit. Care Nurs. Clin. North Am. 2018 30 389 398 10.1016/j.cnc.2018.05.007 30098742

상세보기
3. DeMellow J. Kim T.Y. Technology-enabled performance monitoring in intensive care: An integrative literature review Intensive Crit. Care Nurs. 2018 48 42 51 10.1016/j.iccn.2018.07.003 30054118

상세보기
4. Kouatly I.A. Nassar N. Nizam M. Badr L.K. Evidence on Nurse Staffing Ratios and Patient Outcomes in a Low-Income Country: Implications for Future Research and Practice Worldviews Evid. Based Nurs. 2018 15 353 360 10.1111/wvn.12316 30129163

상세보기
5. Monegro A.F. Regunath H. Hospital Acquired Infections StatPearls Treasure Island, FL, USA 2019
6. Centers for Disease Control and Prevention Nearly Half a Million Americans Suffered from Clostridium Difficile Infections in a Single Year CDC Atlanta, GA, USA 2017
7. Lindsay D. von Holy A. Bacterial biofilms within the clinical setting: What healthcare professionals should know J. Hosp. Infect. 2006 64 313 325 10.1016/j.jhin.2006.06.028 17046102

상세보기
8. Percival S.L. Suleman L. Vuotto C. Donelli G. Healthcare-associated infections, medical devices and biofilms: Risk, tolerance and control J. Med. Microbiol. 2015 64 323 334 10.1099/jmm.0.000032 25670813

상세보기
9. Lowy F.D. Staphylococcus aureus infections N. Engl. J. Med. 1998 339 520 532 10.1056/NEJM199808203390806 9709046

상세보기
10. James G.A. Swogger E. Wolcott R. Pulcini E. Secor P. Sestrich J. Costerton J.W. Stewart P.S. Biofilms in chronic wounds Wound Repair Regen. 2008 16 37 44 10.1111/j.1524-475X.2007.00321.x 18086294

상세보기
11. Anderson G.G. Moreau-Marquis S. Stanton B.A. O’Toole G.A. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells Infect. Immun. 2008 76 1423 1433 10.1128/IAI.01373-07 18212077

상세보기
12. Hoiby N. Ciofu O. Bjarnsholt T. Pseudomonas aeruginosa biofilms in cystic fibrosis Future Microbiol. 2010 5 1663 1674 10.2217/fmb.10.125 21133688

상세보기
13. Cowan M.M. Plant products as antimicrobial agents Clin. Microbiol. Rev. 1999 12 564 582 10.1128/CMR.12.4.564 10515903

상세보기
14. Huber B. Eberl L. Feucht W. Polster J. Influence of polyphenols on bacterial biofilm formation and quorum-sensing Z. Nat. C J. Biosci. 2003 58 879 884 10.1515/znc-2003-11-1224 14713169

상세보기
15. Kumar S. Pandey A.K. Chemistry and biological activities of flavonoids: An overview Sci. World J. 2013 2013 162750 10.1155/2013/162750 24470791

상세보기
16. Sirk T.W. Brown E.F. Friedman M. Sum A.K. Molecular binding of catechins to biomembranes: Relationship to biological activity J. Agric. Food Chem. 2009 57 6720 6728 10.1021/jf900951w 19572638

상세보기
17. Sirk T.W. Brown E.F. Sum A.K. Friedman M. Molecular dynamics study on the biophysical interactions of seven green tea catechins with lipid bilayers of cell membranes J. Agric. Food Chem. 2008 56 7750 7758 10.1021/jf8013298 18672886

상세보기
18. Brackman G. Breyne K. De Rycke R. Vermote A. Van Nieuwerburgh F. Meyer E. Van Calenbergh S. Coenye T. The Quorum Sensing Inhibitor Hamamelitannin Increases Antibiotic Susceptibility of Staphylococcus aureus Biofilms by Affecting Peptidoglycan Biosynthesis and eDNA Release Sci. Rep. 2016 6 20321 10.1038/srep20321 26828772

상세보기
19. Brackman G. Cos P. Maes L. Nelis H.J. Coenye T. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo Antimicrob. Agents Chemother. 2011 55 2655 2661 10.1128/AAC.00045-11 21422204

상세보기
20. Cobrado L. Azevedo M.M. Silva-Dias A. Ramos J.P. Pina-Vaz C. Rodrigues A.G. Cerium, chitosan and hamamelitannin as novel biofilm inhibitors? J. Antimicrob. Chemother. 2012 67 1159 1162 10.1093/jac/dks007 22316569

상세보기
21. Cobrado L. Silva-Dias A. Azevedo M.M. Pina-Vaz C. Rodrigues A.G. In vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infections J. Antimicrob. Chemother. 2013 68 126 130 10.1093/jac/dks376 22991425

상세보기
22. Kiran M.D. Adikesavan N.V. Cirioni O. Giacometti A. Silvestri C. Scalise G. Ghiselli R. Saba V. Orlando F. Shoham M. Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening Mol. Pharmacol. 2008 73 1578 1586 10.1124/mol.107.044164 18314496

상세보기
23. Vermote A. Brackman G. Risseeuw M.D.P. Coenye T. Van Calenbergh S. Novel hamamelitannin analogues for the treatment of biofilm related MRSA infections-A scaffold hopping approach Eur. J. Med. Chem. 2017 127 757 770 10.1016/j.ejmech.2016.10.056 27823882

상세보기
24. Wang H. Provan G.J. Helliwell K. Determination of hamamelitannin, catechins and gallic acid in witch hazel bark, twig and leaf by HPLC J. Pharm. Biomed. Anal. 2003 33 539 544 10.1016/S0731-7085(03)00303-0 14623578

상세보기
25. Pillai S.K. Moellering R.C. Eliopoulos G.M. Antimicrobial Combinations Antibiotics in Laboratory Medicine Lorian V. Lippincott Williams & Wilkins Philadelphia, PA, USA 2005
26. Fratini F. Mancini S. Turchi B. Friscia E. Pistelli L. Giusti G. Cerri D. A novel interpretation of the Fractional Inhibitory Concentration Index: The case Origanum vulgare L. and Leptospermum scoparium J. R. et G. Forst essential oils against Staphylococcus aureus strains Microbiol. Res. 2017 195 11 17 10.1016/j.micres.2016.11.005 28024521

상세보기
27. Huang R.Y. Pei L. Liu Q. Chen S. Dou H. Shu G. Yuan Z.X. Lin J. Peng G. Zhang W. Isobologram Analysis: A Comprehensive Review of Methodology and Current Research Front. Pharmacol. 2019 10 1222 10.3389/fphar.2019.01222 31736746

상세보기
28. Kuang H. Wang W. Xu L. Ma W. Liu L. Wang L. Xu C. Monoclonal antibody-based sandwich ELISA for the detection of staphylococcal enterotoxin A Int. J. Environ. Res. Public Health 2013 10 1598 1608 10.3390/ijerph10041598 23603865

상세보기
29. Rasooly R. Molnar A. Choi H.Y. Do P. Racicot K. Apostolidis E. In-Vitro Inhibition of Staphylococcal Pathogenesis by Witch-Hazel and Green Tea Extracts Antibiotics 2019 8 244 10.3390/antibiotics8040244

상세보기
30. Borges A. Ferreira C. Saavedra M.J. Simoes M. Antibacterial activity and mode of action of ferulic and gallic acids against pathogenic bacteria Microb. Drug Resist. 2013 19 256 265 10.1089/mdr.2012.0244 23480526

상세보기
31. Bielaszewska M. Idelevich E.A. Zhang W. Bauwens A. Schaumburg F. Mellmann A. Peters G. Karch H. Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain Antimicrob. Agents Chemother. 2012 56 3277 3282 10.1128/AAC.06315-11 22391549

상세보기
32. Kimmitt P.T. Harwood C.R. Barer M.R. Toxin gene expression by shiga toxin-producing Escherichia coli: The role of antibiotics and the bacterial SOS response Emerg. Infect. Dis. 2000 6 458 465 10.3201/eid0605.000503 10998375

상세보기
33. Zhang X. McDaniel A.D. Wolf L.E. Keusch G.T. Waldor M.K. Acheson D.W. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice J. Infect. Dis. 2000 181 664 670 10.1086/315239 10669353

상세보기
34. Balaban N. Rasooly A. Staphylococcal enterotoxins Int. J. Food Microbiol. 2000 61 1 10 10.1016/S0168-1605(00)00377-9 11028954

상세보기
35. Friedman M. Rasooly R. Review of the inhibition of biological activities of food-related selected toxins by natural compounds Toxins 2013 5 743 775 10.3390/toxins5040743 23612750

상세보기
36. Rasooly R. Molnar A. Do P. Morroni G. Brescini L. Cirioni O. Giacometti A. Apostolidis E. Witch Hazel Significantly Improves the Efficacy of Commercially Available Teat Dips Pathogens 2020 9 92 10.3390/pathogens9020092 32024049

상세보기
37. Balaban N. Goldkorn T. Gov Y. Hirshberg M. Koyfman N. Matthews H.R. Nhan R.T. Singh B. Uziel O. Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating Protein (TRAP) J. Biol. Chem. 2001 276 2658 2667 10.1074/jbc.M005446200 11160124

상세보기
38. Balaban N. Goldkorn T. Nhan R.T. Dang L.B. Scott S. Ridgley R.M. Rasooly A. Wright S.C. Larrick J.W. Rasooly R. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus Science 1998 280 438 440 10.1126/science.280.5362.438 9545222

상세보기
39. Kiran M.D. Bala S. Hirshberg M. Balaban N. YhgC protects Bacillus anthracis from oxidative stress Int. J. Artif. Organs 2010 33 590 607 10.1177/039139881003300905 20963726

상세보기
40. Kiran M.D. Balaban N. TRAP plays a role in stress response in Staphylococcus aureus Int. J. Artif. Organs 2009 32 592 599 10.1177/039139880903200908 19856271

상세보기
41. Kiran M.D. Giacometti A. Cirioni O. Balaban N. Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors Int. J. Artif. Organs 2008 31 761 770 10.1177/039139880803100903 18924087

상세보기
42. Lopez-Leban F. Kiran M.D. Wolcott R. Balaban N. Molecular mechanisms of RIP, an effective inhibitor of chronic infections Int. J. Artif. Organs 2010 33 582 589 10.1177/039139881003300904 20963725

상세보기
43. Wolcott R. Lopez-Leban F. Kiran M. Balaban N. Wound Healing by an Anti-Staphylococcal Biofilm Approach Biofilm Highlights Hans-Curt F. Wingender J. Szewzyk U. Springer Berlin/Heidelberg, Germany 2011 141 161 10.1007/978-3-642-19940-0_7
44. Cirioni O. Simonetti O. Morroni G. Brescini L. Kamysz W. Kamysz E. Orlando F. Pierpaoli E. Caffarini M. Orciani M. Efficacy of Pexiganan Combination with Tigecycline in a Mouse Model of Pseudomonas aeruginosa Sepsis Curr. Top. Med. Chem. 2018 18 2127 2132 10.2174/1568026619666181219123431 30569865

상세보기
45. Gyawali R. Ibrahim S.A. Natural products as antimicrobial agents Food Control 2014 46 412 429 10.1016/j.foodcont.2014.05.047

상세보기
46. Morroni G. Simonetti O. Brenciani A. Brescini L. Kamysz W. Kamysz E. Neubauer D. Caffarini M. Orciani M. Giovanetti E. In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds Med. Microbiol. Immunol. 2019 208 877 883 10.1007/s00430-019-00624-7 31214759

상세보기
47. Henrick K. Hirshberg M. Structure of the signal transduction protein TRAP (target of RNAIII-activating protein) Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2012 68 744 750 10.1107/S1744309112020167 22750855

상세보기
48. Singh V.K. Jayaswal R.K. Wilkinson B.J. Cell wall-active antibiotic induced proteins of Staphylococcus aureus identified using a proteomic approach FEMS Microbiol. Lett. 2001 199 79 84 10.1016/S0378-1097(01)00163-X 11356571

상세보기

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

whISOBAX TM Inhibits Bacterial Pathogenesis and Enhances the Effect of Antibiotics 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (48)

이 논문을 인용한 문헌

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트